Targeting new mechanisms in blood vessel health and disease
Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms
This study is looking at how blood vessels react to different forces and how these reactions can lead to conditions like atherosclerosis, with the goal of finding new ways to treat these issues so that patients can get better therapies that tackle the real causes of their vascular problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11093499 on NIH RePORTER |
What this research studies
This research investigates how blood vessels respond to mechanical forces and how these responses contribute to diseases like atherosclerosis. It aims to identify new pathways that cause vascular diseases and develop precision nanomedicine approaches to target these pathways directly. By focusing on the unique ways that blood flow affects the endothelium, the research seeks to create more effective treatments for vascular conditions. Patients may benefit from innovative therapies that address the root causes of their vascular diseases rather than just managing symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with atherosclerotic cardiovascular disease.
Not a fit: Patients with non-vascular diseases or those not affected by atherosclerosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking therapies that more effectively treat atherosclerosis and related vascular diseases.
How similar studies have performed: Previous research has shown promise in targeting mechanotransduction pathways in vascular health, indicating potential for success in this novel approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Fang, Yun — University of Chicago
- Study coordinator: Fang, Yun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.